Feed / CDNA

CareDx, Inc.

CDNA

Healthcare · 49.97 -0.2% today

Isolated · not yet confirmedMarket checked 10 Sept, 15:55 GMT-4

Market read

CareDx, Inc.'s current read is isolated; its market group is not confirming.

No new filing conclusion is available. 0 of 17 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 9 directly disclosed connections are confirming.

Company-0.2% todayVolume comparison unavailable
Market group0 of 17 activeConsumer Services · unavailable
Disclosed network0 of 8 confirmingNo filing-linked name is confirming now
What would change this read
  • CDNA's market-adjusted activity becomes unusual and at least one connected name confirms.

Invalidation: The isolated read changes if CDNA's group or a disclosed connection begins moving with it.

Watch this read

Research brief

The story so far

Healthcare · Diagnostics & Research

No new filing conclusion is available. 0 of 17 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 9 directly disclosed connections are confirming.

Evidence that supports

No thresholded supportive filing evidence is available yet.

Evidence that challenges

No thresholded adverse filing evidence is available yet.

What would clarify the read
  • CDNA's market-adjusted activity becomes unusual and at least one connected name confirms.

Company research

Understand the business, not just the ticker

As of Sep 11, 2026
Business model and earnings drivers

Use the company’s filings to identify the few operating, demand, cost, capital and regulatory variables that determine its earnings power.

Key research questions
  • Which operating variable is changing?
  • Is that change durable, cyclical or one-off?
  • What evidence would disprove the current interpretation?
Annual periods9
Price observations319
Usable filing statements78
Verified relationships8
Evidence supporting the case
  • Latest annual revenue changed +13.8% year over year.
  • Foreign exchange has repeated favorable evidence across 4 filings.
Evidence challenging the case
  • Operating margin changed -20.3 percentage points in the latest annual period.
  • Net margin changed -21.4 percentage points in the latest annual period.
Questions before a position
  • EV/sales is 58% below the available filing-peer median; determine whether growth and quality justify the difference.
Longer-term price context

Price as of Sep 10, 2026

49.97
6m+166.3%12m+276.0%24m
Annual trajectory

Reported annual revenue and per-share history. This is accounting history, not a forecast.

PeriodRevenueYoYDiluted EPSShare change
2021-12-31$296.4M+54.2%$-0.59+12.4%
2022-12-31$321.8M+8.6%$-1.44+2.1%
2023-12-31$280.3M-12.9%$-3.54+0.8%
2024-12-31$333.8M+19.1%$0.93+5.3%
2025-12-31$379.8M+13.8%$-0.40-5.9%

What management says matters

Persistent and emerging business drivers

Foreign exchangepositive · 4 filings
Other (expense) income, net Other (expense) income, net decreased by $0.6 million for the three months ended March 31, 2026, compared to the same period in 2025, primarily due to foreign exchange losses during the period.
10-Q · Apr 28, 2026
Capital investment and capacitymixed · 3 filings
Cash Flows from Investing Activities For the year ended December 31, 2025, net cash provided by investing activities was $2.2 million and primarily related to maturities of marketable securities of $154.7 million, partially offset by purchase of marketable se…
10-K · Feb 25, 2026
Legal and regulatory exposuremixed · 3 filings
The decrease in litigation settlement expense was mainly due to the settlement of $5.4 million related to the Securities Class Action lawsuit during the three months ended March 31, 2025, which was partially offset by a $0.6 million settlement related to the…
10-Q · Apr 28, 2026
Pricing and mixmixed · 3 filings
The decrease was primarily due to lower sales and improved manufacturing efficiencies and lower costs resulting from favorable pricing terms negotiated with key manufacturers.
10-Q · Apr 28, 2026

Valuation discipline

Descriptive valuation snapshot

Price/sales 7.0× · EV/sales 6.8×. Comparisons use only industry-matched filing peers.

Scenario scaffold

Mechanical 2.0-year scenarios are available as editable assumptions, not consensus.

Price action

How the market is pricing the story

49.97-0.2% today

Jodie does not have enough daily observations to draw a useful short-term chart for this asset. The latest quoted price was checked 10 Sept, 15:55 GMT-4; this is a coverage limitation, not a flat-price conclusion.

Developments

No sourced recent-development timeline yet

Jodie has not returned a relevant primary source or news item for CDNA. This is an evidence-coverage gap, not a conclusion that nothing material happened.

Business and financial condition

Reported financial figures are not available yet

Jodie has not returned structured SEC XBRL fundamentals for this asset. This is a coverage limitation, not an assessment of the business or its financial health.

Filing analysis

No comparable filing assessment is available yet

Jodie has not yet found a suitable current-versus-prior filing comparison for CDNA. This does not mean the latest filing was neutral or immaterial.

Business ecosystem

The relationships behind CDNA

Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.

Depends on

BDXBecton, Dickinson and CompanysupplierApr 28, 2026

These sole source suppliers include Thermo Fisher Scientific, Inc., or Thermo Fisher, which supplies us with instruments, laboratory reagents and consumables; Roche Molecular Systems, which supplies us with laboratory reagents and consumables; Hamilton Roboti…

ILMNIllumina, Inc.supplierApr 28, 2026

These sole source suppliers include Thermo Fisher Scientific, Inc., or Thermo Fisher, which supplies us with instruments, laboratory reagents and consumables; Roche Molecular Systems, which supplies us with laboratory reagents and consumables; Hamilton Roboti…

Depended on by

NTRANatera, Inc.competitorFeb 27, 2026

In organ health, our primary competitor is CareDx, Inc.

Filing peers

Companies whose filings use similar operating language.

Open the three relationships above to see Jodie’s filing proof. Pro unlocks 6 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →

What is moving around it

Live connections

CDNA is currently a Follower in the organic co-movement group Consumer Services. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.

This group is retained as the last observed read for CDNA; it is not active in the latest market snapshot.

Context history

Theme membership history

No durable theme membership has been observed for this name yet.